<?xml version='1.0' encoding='utf-8'?>
<document id="11808342"><sentence text="[Analysis of the mechanisms of the drug-drug interaction from a view of pharmacogenomics]." /><sentence text="A wide variety of transporters and enzymes are involved in the disposition and metabolism of therapeutic drugs" /><sentence text=" Any compounds interacting with these proteins may inhibit uptake, efflux and/or metabolism of drugs and therefore alter the bioavailability and/or clearance of them" /><sentence text=" Progress in pharmacogenomics throws light on the clarification of mechanisms on drug-drug interaction" /><sentence text=" Various mutation and polymorphisms in drug transporters and metabolic enzymes were identified and some of which alter function of the proteins" /><sentence text=" The steroid and xenobiotic receptor, SXR, coordinately regulated CYP3A4, a major drug metabolizing enzyme and P-glycoprotein, a broad-specificity efflux pump"><entity charOffset="5-12" id="DDI-PubMed.11808342.s6.e0" text="steroid" /></sentence><sentence text=" Now we are in the face of new period of study on drug interaction" /><sentence text=" With the help of pharmacogenomics, it might be possible to someday predict, avoid or manipulate potential cause of drug-drug interactions" /><sentence text="" /></document>